COST OF OUTBREAK OF MENINGOCOCCAL DISEASE IN A COLOMBIAN CARIBBEAN CITY, 2012

Author(s)

Alvis N*1;Pinzon H2, Coronell W3 1Universidad de Cartagena, Cartagena de Indias, Colombia, 2Hospital Infantil Napoleon Franco Perea, Cartagena de Indias, Colombia, 3Universidad de Cartagena, Cartagena, Bolívar, Colombia

OBJECTIVES: To describe the cost of outbreak of meningococcal disease in Cartagena - Colombia.  METHODS: The cost of meningococcal disease outbreak from February 21st thru March 21st2012, were described. The suspected cases were detected in the Children´s Hospital Napoleon Franco Pareja, House of the Child (HC) and they were reported to the Departamento Administrativo Distrital de Salud (DADIS, for acronym in Spanish). We ran an active surveillance program in the neighborhood cases. The investigation costs of the outbreak control, surveillance and health care cost were estimated. RESULTS:  During meningococcal disease outbreak and following 1 month of active surveillance, a total of 6 cases were detected; from which one suspected case, one probable case and four were confirmed cases. The average patient age was 4.6 years. 50% of the cases died, 33% of the cases had meningitis, meningococcemia and myocarditis. 66% of the cases had culture specimen positive with Neisseria meningitidis. 5/6 cases (83%) had RT-PCR positive with Neisseria meningitidis. All N. meningitidiswere serogroup B. 50 doses of ceftriaxone were administered as prophylaxis. DADIS did not recommend meningococcal vaccination and the proper vaccine was not available at the time. The costs of meningococcal outbreak were estimated as follows: Cost of control of the outbreak (US $ 735), disease surveillance phase (US $ 3,935) and health care cost was US $ 4.670. CONCLUSIONS: All cases were caused by N. meningitidis serogroup B. The absence of vaccination involves lower costs in control of the outbreak.

Conference/Value in Health Info

2013-05, ISPOR 2013, New Orleans, LA, USA

Value in Health, Vol. 16, No. 3 (May 2013)

Code

PIN44

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Infectious Disease (non-vaccine), Vaccines

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×